Medicinal cannabis: is Δ9–tetrahydrocannabinol necessary for all its effects?
@article{Wilkinson2003MedicinalCI, title={Medicinal cannabis: is Δ9–tetrahydrocannabinol necessary for all its effects?}, author={J. D. Wilkinson and Benjamin J. Whalley and D. Baker and G. Pryce and A. Constanti and S. Gibbons and Elizabeth Williamson}, journal={Journal of Pharmacy and Pharmacology}, year={2003}, volume={55} }
Cannabis is under clinical investigation to assess its potential for medicinal use, but the question arises as to whether there is any advantage in using cannabis extracts compared with isolated Δ9‐trans‐tetrahydrocannabinol (Δ9THC), the major psychoactive component. We have compared the effect of a standardized cannabis extract (SCE) with pure Δ9THC, at matched concentrations of Δ9THC, and also with a Δ9THC‐free extract (Δ9THC‐free SCE), using two cannabinoid‐sensitive models, a mouse model of… CONTINUE READING
Topics from this paper
68 Citations
Δ9-Tetrahydrocannbinol Accounts for the Antinociceptive, Hypothermic, and Cataleptic Effects of Marijuana in Mice
- Chemistry, Medicine
- Journal of Pharmacology and Experimental Therapeutics
- 2005
- 116
Phytocannabinoids as novel therapeutic agents in CNS disorders.
- Chemistry, Medicine
- Pharmacology & therapeutics
- 2012
- 200
- PDF
Are cannabidiol and Δ9‐tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
- Chemistry, Medicine
- British journal of pharmacology
- 2015
- 279
Pure Δ9-tetrahydrocannabivarin and a Cannabis sativa extract with high content in Δ9-tetrahydrocannabivarin inhibit nitrite production in murine peritoneal macrophages.
- Chemistry, Medicine
- Pharmacological research
- 2016
- 9
Cannabis sativa and the Endogenous Cannabinoid System: Therapeutic Potential for Appetite Regulation
- Biology, Medicine
- Phytotherapy research : PTR
- 2011
- 25
- PDF
Effects of Cannabis sativa extract on haloperidol-induced catalepsy and oxidative stress in the mice
- Medicine
- EXCLI journal
- 2012
- 21
- PDF
Differential effects of cannabis extracts and pure plant cannabinoids on hippocampal neurones and glia
- Chemistry, Medicine
- Neuroscience Letters
- 2006
- 29
- PDF
Development of cannabidiol as a treatment for severe childhood epilepsies
- Medicine
- British journal of pharmacology
- 2020
- PDF
Cannabinoid-Based Medicines for Neurological Disorders—Clinical Evidence
- Medicine
- Molecular Neurobiology
- 2007
- 23
Medicinal cannabis does not influence the clinical pharmacokinetics of irinotecan and docetaxel.
- Medicine
- The oncologist
- 2007
- 49
- PDF
References
SHOWING 1-10 OF 62 REFERENCES
Molecular characterization of a peripheral receptor for cannabinoids
- Biology, Medicine
- Nature
- 1993
- 4,243
Pharmacokinetics and Pharmacodynamics of Cannabinoids
- Chemistry, Medicine
- Clinical pharmacokinetics
- 2003
- 832
- PDF
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
- Chemistry, Medicine
- British journal of pharmacology
- 2001
- 762
- PDF
Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity.
- Chemistry, Medicine
- European journal of pharmacology
- 2002
- 190
- PDF
Comparison of smoked marijuana and oral Δ9-tetrahydrocannabinol in humans
- Psychology
- Psychopharmacology
- 2002
- 131
A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms
- Medicine
- Clinical rehabilitation
- 2003
- 356
- PDF
Endocannabinoids control spasticity in a multiple sclerosis model
- Medicine
- FASEB journal : official publication of the Federation of American Societies for Experimental Biology
- 2001
- 371
- PDF